The modern role of androgen deprivation therapy in the management of localised and locally advanced prostate cancer

INTRODUCTION: Approximately 50% of men diagnosed with prostate cancer will be exposed to androgen deprivation therapy (ADT) at some stage. The role of ADT in the management of metastatic disease has long been recognised, and its place in the management of localised and locally advanced disease has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Gunner, Charlotte, Gulamhusein, Aziz, Rosario, Derek J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2016
Materias:
Changing Face of Prostate Cancer Diagnosis and Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356175/
https://www.ncbi.nlm.nih.gov/pubmed/28344813
http://dx.doi.org/10.1177/2051415816654048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356175/
https://www.ncbi.nlm.nih.gov/pubmed/28344813
http://dx.doi.org/10.1177/2051415816654048

Ejemplares similares